{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:54:46Z","timestamp":1790924086433,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05922-5","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:22Z","timestamp":1790922742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and proliferative responses of the prostate to abrupt versus tapered discontinuation of dutasteride in short- and long-term treated rats"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-0795","authenticated-orcid":false,"given":"Ahmed A.","family":"Morsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezat A.","family":"Mersal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Almuraikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaiath","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Almuslet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa","family":"Almuslet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Almuslet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad Ahmed","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911952","volume":"23","author":"M Alemany","year":"2022","unstructured":"Alemany M (2022) The roles of androgens in humans: biology, metabolic regulation and health. Int J Mol Sci 23:11952","journal-title":"Int J Mol Sci"},{"key":"5922_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16101726","volume":"16","author":"MS Baig","year":"2019","unstructured":"Baig MS, Kolasa-Wo\u0142osiuk A, Pilutin A, Safranow K, Baranowska-Bosiacka I, Kabat-Koperska J, Wiszniewska B (2019) Finasteride-induced inhibition of 5\u03b1-reductase type 2 could lead to kidney damage\u2014animal, experimental study. Int J Environ Res Public Health 16:1726","journal-title":"Int J Environ Res Public Health"},{"key":"5922_CR3","first-page":"126","volume-title":"Bancroft\u2019s theory and practice of histological techniques","author":"JD Bancroft","year":"2018","unstructured":"Bancroft JD, Lyton C (2018) The Hematoxylins and Eosin. In: Suvarna SK, Bancroft JD, Lyton C (eds) Bancroft\u2019s theory and practice of histological techniques. pp 126\u2013138"},{"key":"5922_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/pros.22810","volume":"74","author":"TM Bauman","year":"2014","unstructured":"Bauman TM, Sehgal PD, Johnson KA, Pier T, Bruskewitz RC, Ricke WA, Huang W (2014) Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues. Prostate 74:923\u2013932","journal-title":"Prostate"},{"key":"5922_CR5","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/ERC-20-0517","volume":"28","author":"S Ben-Salem","year":"2021","unstructured":"Ben-Salem S, Venkadakrishnan VB, Heemers HV (2021) Novel insights in cell cycle dysregulation during prostate cancer progression. Endocr Relat Cancer 28:R141\u2013R155","journal-title":"Endocr Relat Cancer"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.21037\/tau-22-690","volume":"12","author":"B Chislett","year":"2023","unstructured":"Chislett B, Chen D, Perera ML, Chung E, Bolton D, Qu LG (2023) 5-Alpha reductase inhibitors use in prostatic disease and beyond. Transl Androl Urol 12:487","journal-title":"Transl Androl Urol"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","volume":"68","author":"L Cindolo","year":"2015","unstructured":"Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, De Nunzio C, Schips L (2015) Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol 68:418\u2013425","journal-title":"Eur Urol"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2613.2008.00618.x","volume":"90","author":"LS Corradi","year":"2009","unstructured":"Corradi LS, Campos SGP, Santos FCA, Vilamaior PSL, Goes RM, Taboga SR (2009) Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages. Int J Exp Pathol 90:79\u201394","journal-title":"Int J Exp Pathol"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cbin.10787","volume":"41","author":"FK Delella","year":"2017","unstructured":"Delella FK, de Almeida FLA, Nunes HC, Rinaldi JC, Felisbino SL (2017) Fibrillar collagen genes are not coordinately upregulated with TGF \u03b21 expression in finasteride\u2010treated prostate. Cell Biol Int 41:1214\u20131222","journal-title":"Cell Biol Int"},{"key":"5922_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100237","volume":"9","author":"C Di Loreto","year":"2014","unstructured":"Di Loreto C, La Marra F, Mazzon G, Belgrano E, Trombetta C, Cauci S (2014) Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia. PLoS ONE 9:e100237","journal-title":"PLoS ONE"},{"key":"5922_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cont.2024.101711","volume":"12","author":"AC Diokno","year":"2024","unstructured":"Diokno AC, Kunta A, Bowen R (2024) Testosterone and 5 alpha reductase inhibitor (5ARI) in benign prostatic hyperplasia (BPH): a historical perspective. Continence (Oxf) 12:101711","journal-title":"Continence (Oxf)"},{"key":"5922_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/andr.12297","volume":"5","author":"N Enatsu","year":"2017","unstructured":"Enatsu N, Chiba K, Sumii K, Fukuda T, Okada K, Matsushita K, Fujisawa M (2017) Dutasteride-mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats. Andrology 5:347\u2013353","journal-title":"Andrology"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","volume":"40","author":"N Formaggio","year":"2021","unstructured":"Formaggio N, Rubin MA, Theurillat J-P (2021) Loss and revival of androgen receptor signaling in advanced prostate cancer. Oncogene 40:1205\u20131216","journal-title":"Oncogene"},{"key":"5922_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/pros.21325","volume":"71","author":"J Hsieh","year":"2011","unstructured":"Hsieh J, Chen S, Yu H, Chang H (2011) Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer. Prostate 71:1115\u20131121","journal-title":"Prostate"},{"key":"5922_CR15","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.21037\/tau-20-843","volume":"9","author":"X Hu","year":"2020","unstructured":"Hu X, Wang Y-H, Yang Z-Q, Shao Y-X, Yang W-X, Li X (2020) Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis. Transl Androl Urol 9:2519","journal-title":"Transl Androl Urol"},{"key":"5922_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5534\/wjmh.180082","volume":"37","author":"SU Jeh","year":"2019","unstructured":"Jeh SU, Yoon S, Choi JH, Do J, Seo DH, Lee SW, Choi SM, Lee C, Kam SC, Hwa JS (2019) Persistent erectile dysfunction after discontinuation of 5-alpha reductase inhibitor therapy in rats depending on the duration of treatment. World J Mens Health 37:240\u2013248","journal-title":"World J Mens Health"},{"key":"5922_CR17","first-page":"454","volume-title":"Histological and histochemical methods. Theory and Practice","author":"JA Kiernan","year":"2015","unstructured":"Kiernan JA (2015) Immunohistochemistry. In: Kiernan J (ed) Histological and histochemical methods. Theory and Practice. Scion Publishing Ltd, pp 454\u2013490"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1111\/bph.16104","volume":"181","author":"KE Knockenhauer","year":"2024","unstructured":"Knockenhauer KE, Copeland RA (2024) The importance of binding kinetics and drug\u2013target residence time in pharmacology. Br J Pharmacol 181:4103\u20134116","journal-title":"Br J Pharmacol"},{"key":"5922_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2025.101044","volume":"25","author":"A Kolasa","year":"2025","unstructured":"Kolasa A, Kur P, Rzeszotek S, Grabowska M, Blatkiewicz M, Freus M, Wilk A (2025) The postnatal offspring of finasteride-treated male rats show altered ER\u03b1 and PCNA expression in the liver. Reprod Biol 25:101044","journal-title":"Reprod Biol"},{"key":"5922_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.70070\/ms7j8w64","volume":"2","author":"ELE Lestari","year":"2024","unstructured":"Lestari ELE, Fitriani NFN (2024) Association between 5\u03b1-reductase inhibitors and prostate cancer mortality. Int J Med Sci Heal Res 2:1\u201312","journal-title":"Int J Med Sci Heal Res"},{"key":"5922_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"5922_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.lfs.2018.04.014","volume":"203","author":"E Nascimento-Gon\u00e7alves","year":"2018","unstructured":"Nascimento-Gon\u00e7alves E, Faustino-Rocha AI, Seixas F, Ginja M, Cola\u00e7o B, Ferreira R, Fardilha M, Oliveira PA (2018) Modelling human prostate cancer: rat models. Life Sci 203:210\u2013224","journal-title":"Life Sci"},{"key":"5922_CR23","doi-asserted-by":"publisher","DOI":"10.17226\/12910","volume-title":"Guide for the care and use of laboratory animals","author":"NIH","year":"2011","unstructured":"NIH (2011) Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, D.C. https:\/\/doi.org\/10.17226\/12910","edition":"8th ed"},{"key":"5922_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00360","author":"AB Opoku-Acheampong","year":"2017","unstructured":"Opoku-Acheampong AB, Henningson JN, Lindshield BL (2017) The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5\u03b1-reductase 1 and 5\u03b1-reductase 2 in TRAMP mouse prostates. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00360","journal-title":"Heliyon"},{"key":"5922_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678X20943823","volume":"40","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab 40:1769\u20131777","journal-title":"J Cereb Blood Flow Metab"},{"key":"5922_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41585-022-00677-z","volume":"20","author":"V Sailer","year":"2023","unstructured":"Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, Pantel K, Schuele R, Taubert H (2023) Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nat Rev Urol 20:158\u2013178","journal-title":"Nat Rev Urol"},{"key":"5922_CR27","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1017\/S1431927620024514","volume":"26","author":"AM Shalaby","year":"2020","unstructured":"Shalaby AM, Alabiad MA, El Shaer DF (2020) Resveratrol ameliorates the seminiferous tubules damages induced by finasteride in adult male rats. Microsc Microanal 26:1176\u20131186","journal-title":"Microsc Microanal"},{"key":"5922_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.urology.2014.12.002","volume":"85","author":"D Wang","year":"2015","unstructured":"Wang D, Zha X, Nagase K, Akino H, Muramatsu I, Ito H, Yokoyama O (2015) Effects of the 5\u03b1-reductase inhibitor dutasteride on rat prostate \u03b11A-adrenergic receptor and its mediated contractility. Urology 85:704-e9","journal-title":"Urology"},{"key":"5922_CR29","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s11154-022-09730-z","volume":"23","author":"K Wel\u00e9n","year":"2022","unstructured":"Wel\u00e9n K, Damber J-E (2022) Androgens, aging, and prostate health. Rev Endocr Metab Disord 23:1221\u20131231","journal-title":"Rev Endocr Metab Disord"},{"key":"5922_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ajpath.2014.10.012","volume":"185","author":"S Wen","year":"2015","unstructured":"Wen S, Chang H-C, Tian J, Shang Z, Niu Y, Chang C (2015) Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer. Am J Pathol 185:293\u2013301","journal-title":"Am J Pathol"},{"key":"5922_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14728214.2024.2363213","volume":"29","author":"J Winograd","year":"2024","unstructured":"Winograd J, Venishetty N, Codelia-Anjum A, Bhojani N, Elterman D, Zorn KC, Te A, Chughtai B (2024) Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update. Expert Opin Emerg Drugs 29:205\u2013217","journal-title":"Expert Opin Emerg Drugs"},{"key":"5922_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00658","volume":"11","author":"Z-J Yu","year":"2020","unstructured":"Yu Z-J, Yan H-L, Xu F-H, Chao H-C, Deng L-H, Xu X-D, Huang J-B, Zeng T (2020) Efficacy and side effects of drugs commonly used for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Front Pharmacol 11:658","journal-title":"Front Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05922-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05922-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05922-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:32:24Z","timestamp":1790922744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05922-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":32,"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05922-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"12 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and accepted by the Research Ethics Committee at the Faculty of Medicine, Fayoum University (approval #: R855\/144).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In some paragraphs of the manuscript, the authors used ChatGPT to enhance academic text and readability. After finishing, the authors reviewed the content and took full accountability for the published content.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}